Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps

Trends in Pharmacological Sciences

Volumn 38, Issue 5, 2017, Pages 448-458

  Ma, Yonggang ^a   Iyer, Rugmani Padmanabhan ^a   Jung, Mira ^a   Czubryt, Michael P ^b   Lindsey, Merry L ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

big data; computational models; extracellular matrix; fibroblast; inflammation; myocardial infarction; omics

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; CHEMOKINE; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; DISCOIDIN DOMAIN RECEPTOR; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR; OSTEONECTIN; REACTIVE OXYGEN METABOLITE; SEPRASE; SERUM RESPONSE FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; UNCLASSIFIED DRUG;

CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HEART FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PHENOTYPE; REVIEW; WOUND HEALING; ANIMAL; MYOFIBROBLAST; PATHOLOGY;

ANIMALS; HUMANS; MYOCARDIAL INFARCTION; MYOFIBROBLASTS;

EID: 85016612898     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2017.03.001     Document Type: Review

References (83)

1. 1 Writing Group Members, et al. Heart Disease and Stroke Statistics – 2016 Update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
2. 2 Travers, J.G., et al. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118 (2016), 1021–1040.
3. 3 Mikawa, T., Gourdie, R.G., Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev. Biol. 174 (1996), 221–232.
4. 4 Cai, C.L., et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454 (2008), 104–108.
5. 5 Ali, S.R., et al. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ. Res. 115 (2014), 625–635.
6. 6 Lajiness, J.D., Conway, S.J., Origin, development, and differentiation of cardiac fibroblasts. J. Mol. Cell. Cardiol. 70 (2014), 2–8.
7. 7 Ma, Y., et al. Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch. 466 (2014), 1113–1127.
8. 8 Yano, T., et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc. Pathol. 14 (2005), 241–246.
9. 9 van Amerongen, M.J., Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 214 (2008), 377–386.
10. 10 Zhou, B., et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121 (2011), 1894–1904.
11. 11 Ruiz-Villalba, A., Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J. Am. Coll. Cardiol. 65 (2015), 2057–2066.
12. 12 Aisagbonhi, O., et al. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis. Model. Mech. 4 (2011), 469–483.
13. 13 Fligny, C., Duffield, J.S., Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Curr. Opin. Rheumatol. 25 (2013), 78–86.
14. 14 Trial, J., et al. Th1/M1 conversion to Th2/M2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblasts. Front. Immunol., 4, 2013, 287.
15. 15 Moore-Morris, T., et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124 (2014), 2921–2934.
16. 16 Teekakirikul, P., et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires TGF-β. J. Clin. Invest. 120 (2010), 3520–3529.
17. 17 Braitsch, C.M., et al. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell. Cardiol. 65 (2013), 108–119.
18. 18 Kurose, H., Mangmool, S., Myofibroblasts and inflammatory cells as players of cardiac fibrosis. Arch. Pharm. Res. 39 (2016), 1100–1113.
19. 19 Krenning, G., et al. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 225 (2010), 631–637.
20. 20 Pinto, A.R., et al. Revisiting cardiac cellular composition. Circ. Res. 118 (2016), 400–409.
21. 21 Acharya, A., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139 (2012), 2139–2149.
22. 22 Kanisicak, O., et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat. Commun., 7, 2016, 12260.
23. 23 Ma, Y., et al. Extracellular matrix and fibroblast communication following myocardial infarction. J. Cardiovasc. Transl. Res. 5 (2012), 848–857.
24. 24 Mork, C., et al. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation 43 (1990), 146–156.
25. 25 Vogel, W.F., et al. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell. Signal. 18 (2006), 1108–1116.
26. 26 Sugimoto, H., et al. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 5 (2006), 1640–1646.
27. 27 Rettig, W.J., et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 53 (1993), 3327–3335.
28. 28 Orlandini, M., Oliviero, S., In fibroblasts Vegf-D expression is induced by cell–cell contact mediated by cadherin-11. J. Biol. Chem. 276 (2001), 6576–6581.
29. 29 Serini, G., et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J. Cell Biol. 142 (1998), 873–881.
30. 30 Frangogiannis, N.G., Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc. Res. 48 (2000), 89–100.
31. 31 Smith, C.L., et al. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 108 (2011), e15–e26.
32. 32 Squires, C.E., et al. Altered fibroblast function following myocardial infarction. J. Mol. Cell. Cardiol. 39 (2005), 699–707.
33. 33 Turner, N.A., Porter, K.E., Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair, 6, 2013, 5.
34. 34 Daskalopoulos, E., Myofibroblasts in the infarct area: concepts and challenges. Microsc. Microanal. 18 (2012), 35–49.
35. 35 van den Borne, S.W., Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7 (2010), 30–37.
36. 36 van den Borne, S.W.M., Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 84 (2009), 273–282.
37. 37 van Nieuwenhoven, F.A., Turner, N.A., The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul. Pharmacol. 58 (2013), 182–188.
38. 38 Shinde, A.V., Frangogiannis, N.G., Fibroblasts in myocardial infarction: a role in inflammation and repair. J. Mol. Cell. Cardiol. 70 (2014), 74–82.
39. 39 Turner, N.A., Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). J. Mol. Cell. Cardiol. 94 (2016), 189–200.
40. 40 Turner, N.A., et al. Interleukin-1α stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 297 (2009), H1117–H1127.
41. 41 Park, S.K., et al. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem. Biophys. Res. Commun. 284 (2001), 966–971.
42. 42 Barcellos-Hoff, M.H., Dix, T.A., Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10 (1996), 1077–1083.
43. 43 Lijnen, P., et al. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J. Hypertens. 24 (2006), 757–766.
44. 44 Hwang, M.W., et al. Neutralization of interleukin-1β in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J. Am. Coll. Cardiol. 38 (2001), 1546–1553.
45. 45 Mitchell, M.D., et al. IL-1β stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H1139–H1147.
46. 46 Palmer, J.N., et al. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J. Clin. Invest. 95 (1995), 2555–2564.
47. 47 Jacobs, M., et al. Tumor necrosis factor-α at acute myocardial infarction in rats and effects on cardiac fibroblasts. J. Mol. Cell. Cardiol. 31 (1999), 1949–1959.
48. 48 Peng, J., et al. Tumor necrosis factor-α-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ. Res. 91 (2002), 1119–1126.
49. 49 Turner, N.A., et al. Mechanism of TNFα-induced IL-1α, IL-1β and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc. Res. 76 (2007), 81–90.
50. 50 Jourdan-Lesaux, C., Extracellular matrix roles during cardiac repair. Life Sci. 87 (2010), 391–400.
51. 51 Dobaczewski, M., et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 107 (2010), 418–428.
52. 52 Gharaee-Kermani, M., et al. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271 (1996), 17779–17784.
53. 53 Frangogiannis, N.G., Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115 (2007), 584–592.
54. 54 Dewald, O., et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96 (2005), 881–889.
55. 55 Freed, D.H., et al. Role of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H514–H522.
56. 56 Dobaczewski, M., et al. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 48 (2010), 504–511.
57. 57 Eckes, B., et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J. Investig. Dermatol. Symp. Proc. 11 (2006), 66–72.
58. 58 van Putten, S., et al. Mechanical control of cardiac myofibroblasts. J. Mol. Cell. Cardiol. 93 (2016), 133–142.
59. 59 Roche, P.L., et al. Role of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype. Am. J. Physiol. Cell. Physiol. 311 (2016), C297–C307.
60. 60 Harada, M., et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126 (2012), 2051–2064.
61. 2+ channel in renal fibrosis. J. Am. Soc. Nephrol. 26 (2015), 1855–1876.
62. 62 Lighthouse, J.K., Small, E.M., Transcriptional control of cardiac fibroblast plasticity. J. Mol. Cell. Cardiol. 91 (2016), 52–60.
63. 63 Elberg, G., et al. MKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells. Am. J. Physiol. Renal Physiol. 294 (2008), F1116–F1128.
64. 64 O'Connor, J.W., Gomez, E.W., Cell adhesion and shape regulate TGF-β1-induced epithelial–myofibroblast transition via MRTF-A signaling. PLoS One, 8, 2013, e83188.
65. 65 Chen, W., Frangogiannis, N.G., Fibroblasts in post-infarction inflammation and cardiac repair. Biochim. Biophys. Acta 1833 (2013), 945–953.
66. 66 Cleutjens, J.P., et al. Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 27 (1995), 1281–1292.
67. 67 Dewald, O., et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 164 (2004), 665–677.
68. 68 Booz, G.W., Baker, K.M., Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc. Res. 30 (1995), 537–543.
69. 69 Lindsey, M.L., et al. A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis. J. Am. Coll. Cardiol. 66 (2015), 1364–1374.
70. 70 Willems, I.E., et al. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol 145 (1994), 868–875.
71. 71 Hermans, K.C., et al. The Janus face of myofibroblasts in the remodeling heart. J. Mol. Cell. Cardiol. 91 (2016), 35–41.
72. 72 Scruggs, S.B., et al. Harnessing the heart of big data. Circ. Res. 116 (2015), 1115–1119.
73. 73 Xie, Y., et al. Cardiac alternans induced by fibroblast–myocyte coupling: mechanistic insights from computational models. Am. J. Physiol. Heart Circ. Physiol. 297 (2009), H775–H784.
74. 74 McDowell, K.S., et al. Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density. Biophys. J. 101 (2011), 1307–1315.
75. 75 Zhan, H.Q., et al. Fibroblast proliferation alters cardiac excitation conduction and contraction: a computational study. J. Zhejiang Univ. Sci. B 15 (2014), 225–242.
76. 76 Sachse, F.B., et al. A model of electrical conduction in cardiac tissue including fibroblasts. Ann. Biomed. Eng. 37 (2009), 874–889.
77. 77 Nim, H.T., et al. CARFMAP: a curated pathway map of cardiac fibroblasts. PLoS One, 10, 2015, e0143274.
78. 78 Zeigler, A.C., et al. Computational modeling of cardiac fibroblasts and fibrosis. J. Mol. Cell. Cardiol. 93 (2016), 73–83.
79. 79 Zeigler, A.C., et al. A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation. J. Mol. Cell. Cardiol. 94 (2016), 72–81.
80. 80 Raza, S., et al. Construction of a large scale integrated map of macrophage pathogen recognition and effector systems. BMC Syst. Biol., 4, 2010, 63.
81. 81 van Nieuwenhoven, F.A., et al. Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function. Matrix Biol. 32 (2013), 399–406.
82. 82 Minicucci, M.F., et al. Heart failure after myocardial infarction: clinical implications and treatment. Clin. Cardiol. 34 (2011), 410–414.
83. 83 Dobaczewski, M., et al. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J. Cardiovasc. Transl. Res. 5 (2012), 837–847.